About me
Jae Won Kim is an accomplished C-level executive currently serving as the COO/CFO at VantAI, a tech-bio company leveraging artificial intelligence for drug discovery. With over 15 years of experience in the healthcare industry including a decade of banking experience, she brings a powerful combination of transaction experience and strategic perspective from Investment Banking and operational leadership. At VantAI, she plays a pivotal role in strategic pharmaceutical partnerships. Prior to VantAI, she served as CFO at Orum Therapeutics, where she led the company's strategic financing initiatives and orchestrated the sale of ORM-6151 to Bristol Myers Squibb for $100 million upfront with a total transaction value up to $180 million. She played a pivotal role in over $100M of financing and an IPO. Prior to joining Orum Therapeutics, she was Director of Healthcare Investment Banking at Citigroup, where she advised on M&A and financing transactions totaling over $15bn for healthcare companies. She holds MBA - JD degrees from Northwestern University and is an attorney at law in New York State.
